Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 32 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (10)
P 2 (2)

Trial Status

Recruiting13
Unknown8
Not Yet Recruiting4
Active Not Recruiting3
Completed2
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 2 completed trials

Clinical Trials (32)

Showing 20 of 20 trials
NCT07553754Recruiting

Plasma Exosomal RNA Signature for Prostate Cancer Bone Metastasis

NCT07546578Active Not Recruiting

Setting Up ctDNA Analysis on Archived Plasma Samples

NCT07475403Phase 2Recruiting

Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer

NCT07467109Not Yet Recruiting

A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of Brain Cancers

NCT07180212Not ApplicableRecruiting

Guiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Bladder Cancer

NCT07130578Recruiting

The Guiding Value of Liquid Biopsy Based on Urinary Tumor DNA/RNA in the Second Transurethral Resection of High-risk Non-muscle Invasive Bladder Cancer

NCT07187635Not ApplicableRecruiting

Guiding Value of Urinary Tumor DNA Testing in Repeat Transurethral Resection of Non-Muscle-Invasive Bladder Cancer

NCT07441499Recruiting

Using Liquid Biopsy Testing to Identify, Monitor, Predict Recurrence in Urothelial Carcinoma

NCT07319104Not Yet Recruiting

Liquid Biopsy in Early Colorectal Lesions

NCT04852653Active Not Recruiting

A Prospective Feasibility Study Evaluating Extracellular Vesicles Obtained by Liquid Biopsy for Neoadjuvant Treatment Response Assessment in Rectal Cancer

NCT05383872Not ApplicableCompleted

Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors

NCT05810402Not ApplicableRecruiting

Liver Cancer and Immunotherapy in the Liquid Biopsy Era

NCT06287814Recruiting

French Assessment of MRD by Liquid Biopsies in Stage III CRC Patients (FRENCH.MRD.CRC)

NCT06287749Recruiting

French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC)

NCT04940507Not ApplicableActive Not Recruiting

BRAINFUL (BRAIN Tumor Focused Ultrasound-enabled Liquid Biopsy) Trial

NCT05227261Completed

Early Detection of Five Common Cancers Using the ctDNA Analysing Test

NCT05940311RecruitingPrimary

Versatile Ampification Single-Molecule Detection in Liquid Biopsy

NCT06672341Not Yet Recruiting

Clinical Studies of Endometrial Cytology and Cervical Methylation Assays in Endometrial Cancer Screening and Fertility-Preservation Evaluation

NCT06287723Not Yet Recruiting

French Assessment of MRD by Liquid Biopsies in Colorectal With Liver Metastasis Patients (FRENCH.MRD.CRLM)

NCT05749341Enrolling By InvitationPrimary

A Liquid Biopsy Diagnostic Techniques for Endometriosis

Scroll to load more

Research Network

Activity Timeline